$Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies$

Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies

The advantages of enoxaparin over unfractionated heparin (UFH) for the treatment of patients with non-ST-segment elevation acute coronary syndromes are well established. However, no data are available about the safety and efficacy in patients who are obese and patients with severe renal impairment....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2003-07, Vol.146 (1), p.33-41
Hauptverfasser:	Spinler, Sarah A, Inverso, Stephanie M, Cohen, Marc, Goodman, Shaun G, Stringer, Kathleen A, Antman, Elliott M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Aged Anticoagulants Anticoagulants - administration & dosage Anticoagulants - therapeutic use Aspirin Biological and medical sciences Cardiology. Vascular system Coronary Disease - complications Coronary Disease - drug therapy Coronary heart disease Drug therapy Enoxaparin - adverse effects Enoxaparin - therapeutic use Female Fibrinolytic Agents - adverse effects Fibrinolytic Agents - therapeutic use Heart Heart attacks Hemorrhage Heparin - adverse effects Heparin - therapeutic use Humans Kidney Diseases - complications Logistic Models Logistics Male Medical sciences Meta-Analysis as Topic Middle Aged Myocardial Infarction - drug therapy Obesity Obesity - complications Randomized Controlled Trials as Topic Retrospective Studies Secondary Prevention Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!